Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date	Form	Description	View
Feb 11, 2021	UPLOAD	UPLOAD	View HTML 0000000000-21-001734.pdf 0000000000-21-001734.rtf
May 18, 2016	UPLOAD	UPLOAD	View HTML 0000000000-16-076961.pdf
Mar 20, 2015	UPLOAD	UPLOAD	View HTML 0000000000-15-016713.pdf
Apr 08, 2015	UPLOAD	UPLOAD	View HTML 0000000000-15-020307.pdf
Dec 02, 2020	UPLOAD	UPLOAD	View HTML 0000000000-20-011535.pdf 0000000000-20-011535.rtf
May 07, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0000315066-15-002590.pdf 0000315066-15-002590.rtf 0000315066-15-002590.xls
May 12, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0001012975-15-000330.pdf 0001012975-15-000330.rtf 0001012975-15-000330.xls
Nov 04, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-014505.pdf 0001179110-15-014505.rtf 0001179110-15-014505.xls
Nov 04, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-014506.pdf 0001179110-15-014506.rtf 0001179110-15-014506.xls
Nov 12, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-014787.pdf 0001179110-15-014787.rtf 0001179110-15-014787.xls

Continue